Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Building Cancer Registries in a Lower Resource Setting: The 10-Year Experience of Golestan, Northern Iran Publisher Pubmed



Roshandel G1 ; Semnani S1 ; Fazel A2 ; Honarvar M3 ; Taziki M2, 4 ; Sedaghat S3 ; Abdolahi N5 ; Ashaari M6 ; Poorabbasi M7 ; Hasanpour S1 ; Hosseini S8 ; Mansuri S9 ; Jahangirrad A10 ; Besharat S1 Show All Authors
Authors
  1. Roshandel G1
  2. Semnani S1
  3. Fazel A2
  4. Honarvar M3
  5. Taziki M2, 4
  6. Sedaghat S3
  7. Abdolahi N5
  8. Ashaari M6
  9. Poorabbasi M7
  10. Hasanpour S1
  11. Hosseini S8
  12. Mansuri S9
  13. Jahangirrad A10
  14. Besharat S1
  15. Moghaddami A3
  16. Mirkarimi H1
  17. Salamat F1
  18. Ghasemikebria F1
  19. Jafari N1
  20. Shokoohifar N1
  21. Gholami M7
  22. Sadjadi A11
  23. Poustchi H11
  24. Bray F12
  25. Malekzadeh R11
Show Affiliations
Authors Affiliations
  1. 1. Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran
  2. 2. Hyrcania Cancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran
  3. 3. Deputy of Public Health, Golestan University of Medical Sciences, Gorgan, Iran
  4. 4. Deputy of Research and Technology, Golestan University of Medical Sciences, Gorgan, Iran
  5. 5. Rheumatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran
  6. 6. Department of Pathology, Sayyad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran
  7. 7. Death Registry Unit, Deputy of Public Health, Golestan University of Medical Sciences, Gorgan, Iran
  8. 8. Deputy of Treatment, Golestan University of Medical Sciences, Gorgan, Iran
  9. 9. Statistics and Information Technology Office, Golestan University of Medical Sciences, Gorgan, Iran
  10. 10. Shafa Radiotherapy Center, 5 Azar Hospital, Gorgan, Iran
  11. 11. Digestive Oncology Research Center, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  12. 12. Cancer Surveillance Section, International Agency for Research on Cancer, Lyon, France

Source: Cancer Epidemiology Published:2018


Abstract

Introduction The Golestan population-based cancer registry (GPCR) was established in Golestan province, Northern Iran, within the Asian belt with predominance of upper-gastrointestinal cancers. We aimed to present the experiences of the registry in a resource–limited setting over the 10 years since its inception (2004–2013). Methods The GPCR was established as a research project to enable sustainable funding. A clear plan was developed for use of the GPCR data. New primary cancers were registered based on international standards, indices of data quality were routinely assessed and age-standardized incidence rates (ASR) per 100,000 person-years calculated using IARC's CanReg-5 software. Results Overall, 19807 new cancer cases were registered during the study period, an average of 1981 cases per annum, with overall ASR of 175.0 and 142.4 in males and females, respectively. The GPCR data suggested gastrointestinal and breast cancers as the most common malignancies in Golestan province. We observed increasing incidence rates of breast and colorectal cancers but declining trends of esophageal cancer. Overall, indices of data quality were within acceptable ranges. Conclusions The GPCR data have been included in IARC's Cancer Incidence in Five Continents series, were used in 21 research projects, and published as 30 research papers. The key ingredients for the successful establishment and maintenance of the GPCR included sustainable sources of funding, a clear action plan for the use of data as well as stakeholder cooperation across all areas of the registration. The GPCR may be considered as a model for planning population-based cancer registries in lesser-resourced settings. © 2017 Elsevier Ltd
Other Related Docs
20. Pancreatic Cancer in Iran - Result of the Iranian National Cancer Registry Program, Asian Pacific Journal of Cancer Prevention (2022)
27. Oral Health and Mortality in the Golestan Cohort Study, International Journal of Epidemiology (2017)
37. Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study, Cancer Epidemiology Biomarkers and Prevention (2018)